quinazolines has been researched along with Vascular Injuries in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hamaguchi, Y; Kawanami, T; Murase, K; Nagaishi, R; Nomiyama, T; Takahashi, H; Tanabe, M; Tanaka, T; Terawaki, Y; Yanase, T | 1 |
1 other study(ies) available for quinazolines and Vascular Injuries
| Article | Year |
|---|---|
Dipeptidyl peptidase-4 inhibitor linagliptin attenuates neointima formation after vascular injury.
Topics: Animals; Blood Glucose; Diabetes Mellitus, Experimental; Dipeptidyl Peptidase 4; Dipeptidyl-Peptidase IV Inhibitors; Glucagon-Like Peptide 1; Hypoglycemic Agents; Linagliptin; Male; Mice, Inbred C57BL; Neointima; Purines; Quinazolines; Vascular System Injuries | 2014 |